United Health Products Stock Performance
| UEEC Stock | USD 0.05 0 2.85% |
The entity has a beta of 1.13, which indicates a somewhat significant risk relative to the market. United Health returns are very sensitive to returns on the market. As the market goes up or down, United Health is expected to follow. At this point, United Health Products has a negative expected return of -0.29%. Please make sure to validate United Health's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if United Health Products performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days United Health Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
United |
United Health Relative Risk vs. Return Landscape
If you would invest 7.80 in United Health Products on October 2, 2025 and sell it today you would lose (2.69) from holding United Health Products or give up 34.49% of portfolio value over 90 days. United Health Products is currently does not generate positive expected returns and assumes 8.9518% risk (volatility on return distribution) over the 90 days horizon. In different words, 80% of otc stocks are less volatile than United, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
United Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for United Health's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as United Health Products, and traders can use it to determine the average amount a United Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0322
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UEEC |
Based on monthly moving average United Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of United Health by adding United Health to a well-diversified portfolio.
United Health Fundamentals Growth
United OTC Stock prices reflect investors' perceptions of the future prospects and financial health of United Health, and United Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on United OTC Stock performance.
| Return On Asset | -5.31 | |||
| Operating Margin | (88.52) % | |||
| Current Valuation | 57.8 M | |||
| Shares Outstanding | 229.47 M | |||
| Price To Earning | (52.33) X | |||
| Price To Book | 5,319 X | |||
| Price To Sales | 1,591 X | |||
| Revenue | 59 | |||
| EBITDA | (29.93 M) | |||
| Cash And Equivalents | 6.42 K | |||
| Total Debt | 666.01 K | |||
| Debt To Equity | 0.62 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (828.08 K) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 26.8 K | |||
| Retained Earnings | (12.44 M) | |||
| Current Asset | 338 K | |||
| Current Liabilities | 1.18 M | |||
About United Health Performance
By analyzing United Health's fundamental ratios, stakeholders can gain valuable insights into United Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if United Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if United Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. United Health Products, Inc. was incorporated in 1997 and is headquartered in Henderson, Nevada. United Health operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.Things to note about United Health Products performance evaluation
Checking the ongoing alerts about United Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for United Health Products help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| United Health generated a negative expected return over the last 90 days | |
| United Health has high historical volatility and very poor performance | |
| United Health has some characteristics of a very speculative penny stock | |
| United Health Products currently holds 666.01 K in liabilities with Debt to Equity (D/E) ratio of 0.63, which is about average as compared to similar companies. United Health Products has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist United Health until it has trouble settling it off, either with new capital or with free cash flow. So, United Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like United Health Products sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for United to invest in growth at high rates of return. When we think about United Health's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 59. Net Loss for the year was (30.55 M) with profit before overhead, payroll, taxes, and interest of 34. | |
| United Health Products currently holds about 6.42 K in cash with (828.08 K) of positive cash flow from operations. | |
| Roughly 16.0% of United Health outstanding shares are owned by insiders |
- Analyzing United Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether United Health's stock is overvalued or undervalued compared to its peers.
- Examining United Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating United Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of United Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of United Health's otc stock. These opinions can provide insight into United Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for United OTC Stock analysis
When running United Health's price analysis, check to measure United Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Health is operating at the current time. Most of United Health's value examination focuses on studying past and present price action to predict the probability of United Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Health's price. Additionally, you may evaluate how the addition of United Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |